Open Access Open Access  Restricted Access Subscription Access

PKC delta Peptide Activator exerts anti-inflammation and cardio-protective effects

Qian Chen


Ischemia followed by reperfusion (I/R) causes additional cell injury.  Reperfusion injury is initiated by vascular endothelial dysfunction and/or oxidative stress, which is further augmented by leukocytes (i.e., polymorphonuclear leukocyte [PMN]) activation and recruitment.  Protein kinase C (PKC) is a key signaling molecule mediating reperfusion injury.  The role of PKC delta (d) isoform in myocardial I/R injury is still being debated.  In this study, we tested the effects of PKC d peptide activator (PKC d+) on inflammation and PMN-induced postreperfused cardiac function.  We found that PKC d+ significantly reduced phorbol-12-myristate-13-acetate (PMA, 15 nM)-induced superoxide (SO) release in isolated rat PMNs. Furthermore, PKC d+ (5 and 10 mM, both n = 5) dose-dependently decreased NG-nitro-L-arginine methyl ester (L-NAME)-induced leukocyte-endothelial interactions in rat mesenteric microcirculation in vivo by intravital microscopy. Lastly, we tested the effects of PKC d+ on I/R+PMNs-induced postreperfused cardiac dysfunction in isolated perfused rat hearts.  We found that PKC d+ (10 mM, n = 6) significantly attenuated PMN-induced cardiac dysfunction as compared with control I/R+PMNs hearts (n = 10) in left ventricular developed pressure (LVDP), end diastolic pressure (EDP), and the maximal rate of LVDP (+dP/dtmax; all P<0.05).  We also found that PKC d+ treated postreperfused heart tissue showed significantly lower leukocyte vascular adherence and tissue infiltration. These results suggest that PKC d+ attenuated PMN-induced post I/R cardiac contractile and diastolic dysfunction, possibly by inhibiting leukocyte-endothelial interactions and attenuating PMN SO release.


Ischemia/reperfusion injury, PKC delta isoform, Superoxide, Leukocyte-endothelial interactions, Cardiac function

Full Text:


Arumugam, T. V., I. A. Shiels, T. M. Woodruff, D. N. Granger and S. M. Taylor (2004). "The role of the complement system in ischemia-reperfusion injury." Shock 21(5): 401-409. (http://www.ncbi.nlm.nih.gov/pubmed/15087815)

Budas, G. R., E. N. Churchill and D. Mochly-Rosen (2007). "Cardioprotective mechanisms of PKC isozyme-selective activators and inhibitors in the treatment of ischemia-reperfusion injury." Pharmacol Res 55(6): 523-536. (http://www.ncbi.nlm.nih.gov/pubmed/17576073)

Chen, C., B. Rueter, S. Krass, C. Zambrano, S. Thomas, C. Prince, B. Bell, V. Chai, J. Emrich and L. H. Young (2010). "The potential clinical application of protein kinase C beta II peptide inhibitor or Gö 6983 in vascular endothelial dysfunction." Curr Top Pharmacol 14: 11-24.( http://www.researchtrends.net/tia/abstract.asp?in=0&vn=14&tid=11&aid=3050&pub=2010&type=)

Chen, L., H. Hahn, G. Wu, C. H. Chen, T. Liron, D. Schechtman, G. Cavallaro, L. Banci, Y. Guo, R. Bolli, G. W. Dorn, 2nd and D. Mochly-Rosen (2001). "Opposing cardioprotective actions and parallel hypertrophic effects of delta PKC and epsilon PKC." Proc Natl Acad Sci U S A 98(20): 11114-11119. (http://www.ncbi.nlm.nih.gov/pubmed/11553773)

Churchill, E., G. Budas, A. Vallentin, T. Koyanagi and D. Mochly-Rosen (2008). "PKC isozymes in chronic cardiac disease: possible therapeutic targets?" Annu Rev Pharmacol Toxicol 48: 569-599. (http://www.ncbi.nlm.nih.gov/pubmed/17919087)

Churchill, E. N. and L. I. Szweda (2005). "Translocation of deltaPKC to mitochondria during cardiac reperfusion enhances superoxide anion production and induces loss in mitochondrial function." Arch Biochem Biophys 439(2): 194-199. (http://www.ncbi.nlm.nih.gov/pubmed/15963450)

Duilio, C., G. Ambrosio, P. Kuppusamy, A. DiPaula, L. C. Becker and J. L. Zweier (2001). "Neutrophils are primary source of O2 radicals during reperfusion after prolonged myocardial ischemia." Am J Physiol Heart Circ Physiol 280(6): H2649-2657. (http://www.ncbi.nlm.nih.gov/pubmed/11356621)

Hausenloy, D. J. and D. M. Yellon (2009). "Preconditioning and postconditioning: underlying mechanisms and clinical application." Atherosclerosis 204(2): 334-341. (http://www.ncbi.nlm.nih.gov/pubmed/19081095)

Inagaki, K., H. S. Hahn, G. W. Dorn, 2nd and D. Mochly-Rosen (2003). "Additive protection of the ischemic heart ex vivo by combined treatment with delta-protein kinase C inhibitor and epsilon-protein kinase C activator." Circulation 108(7): 869-875. (http://www.ncbi.nlm.nih.gov/pubmed/12860903)

Inagaki, K., Y. Kihara, W. Hayashida, T. Izumi, Y. Iwanaga, T. Yoneda, Y. Takeuchi, K. Suyama, E. Muso and S. Sasayama (2000). "Anti-ischemic effect of a novel cardioprotective agent, JTV519, is mediated through specific activation of delta-isoform of protein kinase C in rat ventricular myocardium." Circulation 101(7): 797-804. (http://www.ncbi.nlm.nih.gov/pubmed/10683355)

Kilpatrick, L. E., Y. H. Song, M. W. Rossi and H. M. Korchak (2000). "Serine phosphorylation of p60 tumor necrosis factor receptor by PKC-delta in TNF-alpha-activated neutrophils." Am J Physiol Cell Physiol 279(6): C2011-2018. (http://www.ncbi.nlm.nih.gov/pubmed/11078718)

Korchak, H. M., M. W. Rossi and L. E. Kilpatrick (1998). "Selective role for beta-protein kinase C in signaling for O-2 generation but not degranulation or adherence in differentiated HL60 cells." J Biol Chem 273(42): 27292-27299. (http://www.ncbi.nlm.nih.gov/pubmed/9765254)

Kwak, H. J., K. M. Park, H. E. Choi, H. J. Lim, J. H. Park and H. Y. Park (2010). "The cardioprotective effects of zileuton, a 5-lipoxygenase inhibitor, are mediated by COX-2 via activation of PKC delta." Cell Signal 22(1): 80-87. (http://www.ncbi.nlm.nih.gov/pubmed/19781629)

Laudanna, C., D. Mochly-Rosen, T. Liron, G. Constantin and E. C. Butcher (1998). "Evidence of zeta protein kinase C involvement in polymorphonuclear neutrophil integrin-dependent adhesion and chemotaxis." J Biol Chem 273(46): 30306-30315. (http://www.ncbi.nlm.nih.gov/pubmed/9804792)

Lefer, A. M. and D. J. Lefer (1996). "The role of nitric oxide and cell adhesion molecules on the microcirculation in ischaemia-reperfusion." Cardiovasc Res 32(4): 743-751. (http://www.ncbi.nlm.nih.gov/pubmed/8915192)

Liao, Y. F., Y. C. Hung, W. H. Chang, G. J. Tsay, T. C. Hour, H. C. Hung and G. Y. Liu (2005). "The PKC delta inhibitor, rottlerin, induces apoptosis of haematopoietic cell lines through mitochondrial membrane depolarization and caspases' cascade." Life Sci 77(6): 707-719. (http://www.ncbi.nlm.nih.gov/pubmed/15922001)

Lucchesi, B. R., S. W. Werns and J. C. Fantone (1989). "The role of the neutrophil and free radicals in ischemic myocardial injury." J Mol Cell Cardiol 21(12): 1241-1251. (http://www.ncbi.nlm.nih.gov/pubmed/2698962)

Majumdar, S., M. W. Rossi, T. Fujiki, W. A. Phillips, S. Disa, C. F. Queen, R. B. Johnston, Jr., O. M. Rosen, B. E. Corkey and H. M. Korchak (1991). "Protein kinase C isotypes and signaling in neutrophils. Differential substrate specificities of a translocatable calcium- and phospholipid-dependent beta-protein kinase C and a phospholipid-dependent protein kinase which is inhibited by long chain fatty acyl coenzyme A." J Biol Chem 266(14): 9285-9294. (http://www.ncbi.nlm.nih.gov/pubmed/2026625)

Mao, J. T., I. H. Tsu, S. M. Dubinett, B. Adams, T. Sarafian, F. Baratelli, M. D. Roth and K. J. Serio (2004). "Modulation of pulmonary leukotriene B4 production by cyclooxygenase-2 inhibitors and lipopolysaccharide." Clin Cancer Res 10(20): 6872-6878. (http://www.ncbi.nlm.nih.gov/pubmed/15501964)

Mayr, M., Y. L. Chung, U. Mayr, E. McGregor, H. Troy, G. Baier, M. Leitges, M. J. Dunn, J. R. Griffiths and Q. Xu (2004). "Loss of PKC-delta alters cardiac metabolism." Am J Physiol Heart Circ Physiol 287(2): H937-945. (http://www.ncbi.nlm.nih.gov/pubmed/15277208)

Mayr, M., B. Metzler, Y. L. Chung, E. McGregor, U. Mayr, H. Troy, Y. Hu, M. Leitges, O. Pachinger, J. R. Griffiths, M. J. Dunn and Q. Xu (2004). "Ischemic preconditioning exaggerates cardiac damage in PKC-delta null mice." Am J Physiol Heart Circ Physiol 287(2): H946-956. (http://www.ncbi.nlm.nih.gov/pubmed/15277209)

Mitchell, M. B., X. Meng, L. Ao, J. M. Brown, A. H. Harken and A. Banerjee (1995). "Preconditioning of isolated rat heart is mediated by protein kinase C." Circ Res 76(1): 73-81. (http://www.ncbi.nlm.nih.gov/pubmed/8001280)

Nishizuka, Y. (1992). "Intracellular signaling by hydrolysis of phospholipids and activation of protein kinase C." Science 258(5082): 607-614. (http://www.ncbi.nlm.nih.gov/pubmed/1411571)

Omiyi, D., R. J. Brue, P. Taormina, 2nd, M. Harvey, N. Atkinson and L. H. Young (2005). "Protein kinase C betaII peptide inhibitor exerts cardioprotective effects in rat cardiac ischemia/reperfusion injury." J Pharmacol Exp Ther 314(2): 542-551. (http://www.ncbi.nlm.nih.gov/pubmed/15878997)

Perkins, K. A., S. Pershad, Q. Chen, S. McGraw, J. S. Adams, C. Zambrano, S. Krass, J. Emrich, B. Bell, M. Iyamu, C. Prince, H. Kay, J. C. Teng and L. H. Young (2012). "The effects of modulating eNOS activity and coupling in ischemia/reperfusion (I/R)." Naunyn Schmiedebergs Arch Pharmacol 385(1): 27-38. (http://www.ncbi.nlm.nih.gov/pubmed/21947254)

Peterman, E. E., P. Taormina, 2nd, M. Harvey and L. H. Young (2004). "Go 6983 exerts cardioprotective effects in myocardial ischemia/reperfusion." J Cardiovasc Pharmacol 43(5): 645-656. (http://www.ncbi.nlm.nih.gov/pubmed/15071351)

Phillipson, A., E. E. Peterman, P. Taormina, Jr., M. Harvey, R. J. Brue, N. Atkinson, D. Omiyi, U. Chukwu and L. H. Young (2005). "Protein kinase C-zeta inhibition exerts cardioprotective effects in ischemia-reperfusion injury." Am J Physiol Heart Circ Physiol 289(2): H898-907. (http://www.ncbi.nlm.nih.gov/pubmed/15792991)

Pomerantz, B. J., T. N. Robinson, J. K. Heimbach, C. M. Calkins, S. A. Miller, A. Banerjee and A. H. Harken (2000). "Selective mitochondrial KATP channel opening controls human myocardial preconditioning: too much of a good thing?" Surgery 128(2): 368-373. (http://www.ncbi.nlm.nih.gov/pubmed/10923018)

Shandelya, S. M., P. Kuppusamy, M. L. Weisfeldt and J. L. Zweier (1993). "Evaluation of the role of polymorphonuclear leukocytes on contractile function in myocardial reperfusion injury. Evidence for plasma-mediated leukocyte activation." Circulation 87(2): 536-546. (http://www.ncbi.nlm.nih.gov/pubmed/8381059)

Strasser, R. H., R. Braun-Dullaeus, H. Walendzik and R. Marquetant (1992). "Alpha 1-receptor-independent activation of protein kinase C in acute myocardial ischemia. Mechanisms for sensitization of the adenylyl cyclase system." Circ Res 70(6): 1304-1312. (http://www.ncbi.nlm.nih.gov/pubmed/1315640)

Teng, J. C., H. Kay, Q. Chen, J. S. Adams, C. Grilli, G. Guglielmello, C. Zambrano, S. Krass, A. Bell and L. H. Young (2008). "Mechanisms related to the cardioprotective effects of protein kinase C epsilon (PKC epsilon) peptide activator or inhibitor in rat ischemia/reperfusion injury." Naunyn Schmiedebergs Arch Pharmacol 378(1): 1-15. (http://www.ncbi.nlm.nih.gov/pubmed/18496674)

Tsao, P. S. and A. M. Lefer (1990). "Time course and mechanism of endothelial dysfunction in isolated ischemic- and hypoxic-perfused rat hearts." Am J Physiol 259(6 Pt 2): H1660-1666. (http://www.ncbi.nlm.nih.gov/pubmed/2260693)

Vinten-Johansen, J. (2004). "Involvement of neutrophils in the pathogenesis of lethal myocardial reperfusion injury." Cardiovasc Res 61(3): 481-497. (http://www.ncbi.nlm.nih.gov/pubmed/14962479)

Wang, Y., K. Hirai and M. Ashraf (1999). "Activation of mitochondrial ATP-sensitive K(+) channel for cardiac protection against ischemic injury is dependent on protein kinase C activity." Circ Res 85(8): 731-741. (http://www.ncbi.nlm.nih.gov/pubmed/10521247)

Yellon, D. M. and D. J. Hausenloy (2007). "Myocardial reperfusion injury." N Engl J Med 357(11): 1121-1135. (http://www.ncbi.nlm.nih.gov/pubmed/17855673)

Yoshida, K. (2007). "PKCdelta signaling: mechanisms of DNA damage response and apoptosis." Cell Signal 19(5): 892-901. (http://www.ncbi.nlm.nih.gov/pubmed/17336499)

Young, L. H., B. J. Balin and M. T. Weis (2005). "Go 6983: a fast acting protein kinase C inhibitor that attenuates myocardial ischemia/reperfusion injury." Cardiovasc Drug Rev 23(3): 255-272. (http://www.ncbi.nlm.nih.gov/pubmed/16252018)

Young, L. H., Y. Ikeda and A. M. Lefer (2001). "Protein kinase inhibition exerts cardioprotective effects in myocardial ischemia/reperfusion via inhibition of superoxide release." Methods Find Exp Clin Pharmacol 23(3): 107-114. (http://www.ncbi.nlm.nih.gov/pubmed/11523308)

Zhang, W. L., Y. L. Zhao, X. M. Liu, J. Chen and D. Zhang (2011). "Protective role of mitochondrial K-ATP channel and mitochondrial membrane transport pore in rat kidney ischemic postconditioning." Chin Med J (Engl) 124(14): 2191-2195. (http://www.ncbi.nlm.nih.gov/pubmed/21933625)

Zhao, J., O. Renner, L. Wightman, P. H. Sugden, L. Stewart, A. D. Miller, D. S. Latchman and M. S. Marber (1998). "The expression of constitutively active isotypes of protein kinase C to investigate preconditioning." J Biol Chem 273(36): 23072-23079. (http://www.ncbi.nlm.nih.gov/pubmed/9722533)

Zhao, Z. Q. and J. Vinten-Johansen (2006). "Postconditioning: reduction of reperfusion-induced injury." Cardiovasc Res 70(2): 200-211. (http://www.ncbi.nlm.nih.gov/pubmed/16545349)

DOI: http://dx.doi.org/10.18103/mra.v0i2.62


  • There are currently no refbacks.